1-Methyl-4-(6-methylhept-5-en-2-ylidene)cyclohex-1-ene
CAS: 495-62-5
Ref. 3D-AAA49562
25g | A consultar | ||
50g | A consultar | ||
100g | A consultar |
Información del producto
- (4Z)-4-(1,5-dimethylhex-4-en-1-ylidene)-1-methylcyclohexene
- 1-Methyl-4-(1,5-dimethyl-4-hexenylidene)-1-cyclohexene
- 1-Methyl-4-(5-Methyl-1-Methylidenehex-4-En-1-Yl)Cyclohexene
- 2-Heptene, 2-methyl-6-(4-methyl-3-cyclohexen-1-ylidene)-
- 2-Heptene, 2-methyl-6-(4-methyl-3-cyclohexen-1-ylidene)- (7CI,8CI)
- 2-Methyl-6-(4-methyl-3-cyclohexen-1-ylidene)-2-heptene
- 4-(1,5-Dimethyl-4-hexen-1-ylidene)-1-methylcyclohexene
- 4-(1,5-Dimethyl-4-hexenylidene)-1-methylcyclohexene
- 6-Methyl-2-(4-methylcyclohex-3-enyl)hept-1,5-diene
- Bisabolene (6CI)
- Ver más sinónimos
- Bisabolene (natural)
- Cyclohexene, 4-(1,5-dimethyl-4-hexen-1-ylidene)-1-methyl-
- Cyclohexene, 4-(1,5-dimethyl-4-hexenylidene)-1-methyl-
- FEMA No. 3331
- Limene
- Unii-E452K502K0
- γ-Bisabolene
- Bisabolene
1-Methyl-4-(6-methylhept-5-en-2-ylidene)cyclohex-1-ene is a synthetic cannabinoid that binds to the CB1 and CB2 receptors. It has been shown to have antiinflammatory activity in rat models, as well as inhibitory effects on protein synthesis. This drug is also an effective treatment for infectious diseases such as HIV, influenza and malaria. 1-Methyl-4-(6-methylhept-5-en-2-ylidene)cyclohex-1-ene inhibits HIV transcription by binding to the p65 subunit of NFκB, which regulates the expression of many genes, including those involved in viral replication. This compound has also been shown to inhibit protein synthesis in bacteria by binding to the bacterial ribosome.
1 Methyl 4 (6 methylhept 5 en 2 ylidene)cyclohex 1 ene is a terpene that can be
Propiedades químicas
Consulta técnica sobre: 3D-AAA49562 1-Methyl-4-(6-methylhept-5-en-2-ylidene)cyclohex-1-ene
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.